South Korea-based molecular diagnostics company Seegene Inc announced on Wednesday it is advancing CURECA, a new system currently under development.

The CURECA system is designed to streamline automation in Polymerase Chain Reaction (PCR) testing and laboratory environments.

Seegene will showcase a conceptual video introducing the CURECA system at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025), held 11-15 April in Vienna, Austria. A physical demonstration of the system is expected to take place in July 2025 at the Association for Diagnostics & Laboratory Medicine (ADLM 2025) in Chicago.

CURECA -- short for Continuous Unlimited Random access Expandable and Customizable full Automation -- is Seegene's envisioned PCR testing solution, intended to enable full automation of the PCR testing workflow. The system is expected to include two core components: the Customizable Pre-treatment System (CPS), responsible for sample loading and pre-treatment processing; and Customisable and Expandable Full Automation (CEFA), which will carry out sample loading and preparation for nucleic acid extraction, PCR setup, gene amplification, and result analysis.